For the roughly half of adults over 30 living with significant periodontal disease, the standard clinical dilemma has long been whether to add antibiotics to mechanical cleaning — and which ones. A head-to-head trial now raises a clinically important alternative: an anti-inflammatory regimen without antibiotics may work just as well, a finding with real implications given rising concerns about antibiotic stewardship in dentistry.
This multicenter, double-blind, placebo-controlled randomized trial enrolled 109 adults with Stage III or IV periodontitis — the most severe classifications — and assigned them to one of four arms: subgingival instrumentation alone (SI), SI plus metronidazole 400 mg and amoxicillin 500 mg three times daily for 14 days, SI plus omega-3 fatty acids (3 g/day) and low-dose aspirin (100 mg/day) for six months, or the full combination of both adjunctive protocols. At the one-year mark, roughly 57–59% of patients in each of the three adjunctive treatment groups reached the defined treatment endpoint — no more than four sites with probing depths at or above 5 mm — compared with only 23% in the mechanical-therapy-only group. Critically, combining antibiotics with immunomodulators offered no measurable additional benefit over either approach used alone.
This trial fills a meaningful evidence gap. Omega-3 supplementation and low-dose aspirin act through pro-resolving lipid mediator pathways rather than by directly killing bacteria, meaning they target the host inflammatory response rather than the microbial load — a mechanistically distinct strategy. The equivalence observed here is notable, though the 109-patient cohort limits statistical power to detect moderate effect-size differences between active arms. The one-year follow-up is longer than most adjunctive periodontitis trials but still does not address durability beyond that window. Perhaps most practically significant: this evidence supports omega-3 plus low-dose aspirin as a legitimate antibiotic-sparing option for appropriate patients — an incremental but genuinely useful contribution to the growing literature on host-modulation therapy in periodontal disease.